Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Intermuscular coherence as a candidate biomarker for primary lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: July 13, 2026
Splicing modulation of ATXN2 as a therapeutic strategy to regulate Ataxin-2 protein levels in ALS.
Journal: Neurobiology of disease
Published: April 22, 2026
Phase 2 Clinical Trial of MK-1942, a Negative Allosteric Modulator of Metabotropic Glutamate Receptor 2, for Treatment-Resistant Depression.
Journal: Journal of clinical psychopharmacology
Published: October 13, 2025
Intermuscular coherence from muscle pairs in the leg as a biomarker for amyotrophic lateral sclerosis.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: January 20, 2025
Uncovering codon usage patterns during murine embryogenesis and tissue-specific developmental diseases.
Journal: Frontiers in genetics
Published: January 07, 2025
Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer's Disease.
Journal: ACS chemical biology
Published: December 19, 2024
Glucosylsphingosine is a potential fluid-based biomarker of lysosomal dysfunction in Cln3Δex7/8 mice.
Journal: Neurobiology of disease
Published: November 18, 2024
Preclinical evaluation of MK-8189: A novel phosphodiesterase 10A inhibitor for the treatment of schizophrenia.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 19, 2024
Last Updated: 09/26/2026